Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Expense ratio components for Dividend Aristocrats ETFs include management fees and other ongoing costs that reduce net returns.
20,481 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
A landmark housing bill cleared Congress this week, promising to ease rents and expand homebuilding. President Trump ...
What happens when AI breakthroughs and high-flying tech bets collide with political markets? This article explains th...
When a titan like Alphabet slides, investors often panic. This time, the dip could unlock value. Here are three megac...
Tenable has bumped higher again, fueled by fresh analyst optimism and stronger demand for cybersecurity tools. This g...
An upbeat analyst stance helped lift shares of the first watch restaurant group. This article breaks down the catalys...
A surprise leadership shift at JPMorgan ends years of grooming female executives for the corner office. Marianne Lake...
President Trump asserted Walmart trimmed prices at the administration's request to celebrate the 250th birthday, but ...
Prediction markets show divergent odds for Stripe, Discord, and Anduril IPOs as of July 2026. Traders weigh S-1 timin...
SpaceX stock has retraced from its post-IPO highs, leaving questions about future gains. This guide breaks down why t...
A landmark agreement between Apple and Broadcom signals a major shift in chip strategy and domestic manufacturing. Th...